Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;92(1093):20170955.
doi: 10.1259/bjr.20170955. Epub 2018 Mar 14.

Tumor oxygenation and cancer therapy-then and now

Veronica S Hughes  1 , Jennifer M Wiggins  1 , Dietmar W Siemann  1
Affiliations
Review

Tumor oxygenation and cancer therapy-then and now

Veronica S Hughes et al. Br J Radiol. 2019 Jan.

Abstract

In 2012, cancer affected 14.1 million people worldwide and was responsible for 8.2 million deaths. The disease predominantly affects aged populations and is one of the leading causes of death in most western countries. In tumors, the aggressive growth of the neoplastic cell population and associated overexpression of pro-angiogenic factors lead to the development of disorganized blood vessel networks that are structurally and functionally different from normal vasculature. A disorganized labyrinth of vessels that are immature, tortuous and hyperpermeable typifies tumor vasculature. Functionally, the ability of the tumor vasculature to deliver nutrients and remove waste products is severely diminished. A critical consequence of the inadequate vascular networks in solid tumors is the development of regions of hypoxia [low oxygen tensions typically defined as oxygen tensions (pO2 values) < 10 mm Hg]. Tumor cells existing in such hypoxic environments have long been known to be resistant to anticancer therapy, display an aggressive phenotype, and promote tumor progression and dissemination. This review discusses the physiological basis of hypoxia, methods of detection, and strategies to overcome the resulting therapy resistance.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Fixed section of a human squamous cell carcinoma of the bronchus stained by hematoxylin and eosin. Modified with permission from Thomlinson and Gray.
Figure 2.
Figure 2.
(a) Distribution of hypoxia, identified by the bioreductive nitroimidazole agent EF5 (green) and the endogenous hypoxia marker HIF-1 (red), in human cervical carcinoma (SiHa) xenograft with respect to blood vessel localization (CD31, blue). Image courtesy of D. Hedley. (b) Murine mammary carcinoma (4T1) after intravenous injection with Hoechst-33342 (40 mg kg–1, blue) as a surrogate marker for perfusion, and stained with EF5 (red) and CD31 (green). Please see the online version of this publication for colour images.
Figure 3.
Figure 3.
Patient with a FAZA PET positive oropharyngeal cancer. Reprinted with permission from Mortensen et al. FAZA is a PET tracer developed as a hypoxia identification method for preclinical and clinical application. FAZA, 18F-Fluoroazomycin arabinoside.
Figure 4.
Figure 4.
Illustration of tumor cells growing as a cord around blood vessels from which they obtain oxygen and nutrients. The left side illustrates oxygen diffusion and utilization from the vessel resulting in the development of chronically hypoxic cells at the outer edge of the cord. The right side shows perfusion through the vessel that has been transiently compromised and results in the development of acute hypoxia; examples of the types of flow/oxygen changes reported during a 60-min period are illustrated in the four panels below. Reprinted with permission from Horsman et al.
Figure 5.
Figure 5.
Effect of hypoxic modification in cancer patients treated with primary radiotherapy. Data are from 86 randomized trials including 10,108 patients with either bladder, cervical, head and neck, CNS, lung or other types of cancer such as esophagus and pancreas. Reprinted with permission from Overgaard.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Schwarz G. Ueber Desensibilisierung gegen röntgen- und radiumstrahlen. Munchener Medizinische Wochenschrift 1909; 24: 1–2.
    1. Mottram JC. A factor of importance in the radio sensitivity of tumours. Br J Radiol 1936; 9: 606–14. doi: 10.1259/0007-1285-9-105-606 - DOI
    1. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 1953; 26: 638–48. doi: 10.1259/0007-1285-26-312-638 - DOI - PubMed
    1. Scott OC. Some aspects of the effect of ionizing radiation on tumors in experimental animals. Adv Biol Med Phys 1958; 6: 121–73. - PubMed
    1. Scott OC. A model system for examining the radiosensitivity of metabolising layers of cells. Br J Cancer 1957; 11: 130–6. doi: 10.1038/bjc.1957.19 - DOI - PMC - PubMed